Health care startups that raised Series B in Boston, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Superluminal Medicines | Boston | Series B | $65.5M | 2026-09-03 |
| Beacon Biosignals | Boston | Series B | $11.0M | 2026-04-06 |
| Precede Biosciences | Boston | Series B | $63.5M | 2026-01-12 |
| VideaHealth | Boston | Series B | $40.0M | 2025-01-28 |
| ZOE | Boston | Series B | $15.0M | 2024-07-29 |
| GRO Biosciences | Boston | Series B | $60.3M | 2024-07-19 |
| Cardurion Pharmaceuticals | Boston | Series B | $260.0M | 2024-07-16 |
| Form Health | Boston | Series B | $38.0M | 2024-06-26 |
8 rows of the CSV in 5 of its 18 columns.
- The 61 health care startups in Boston, Massachusetts whose last round is Series B have raised $4.9B in total.
- 8 of them closed their most recent round in the last 12 months, $553.2M combined.
- The largest of those rounds is Soufflé Therapeutics' $135.0M Series B, dated October 2026.
- General Catalyst is an investor in 2 of them, more than any other fund.
- Biotech is the most common other sector, with 37 companies (61%).
- 13% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (39% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
10 of 61| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Series B | $65.5M | 2026-09-03 | $223.5M | Insight Partners, RA Capital Management, NVentures | 11 to 50 | 2022 |
| Beacon Biosignals | Beacon Biosignals uses neurotechnology to measure brain activity for clinical trials and patient treatment. | Artificial intelligence | Series B | $11.0M | 2026-04-06 | $127.0M | General Catalyst, Half Court Ventures, Indicator Ventures +1 | 101 to 250 | 2019 |
| Precede Biosciences | Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. | Biotech | Series B | $63.5M | 2026-01-12 | $140.5M | Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 | 11 to 50 | 2005 |
| VideaHealth | VideaHealth offers dentistAI software that automatically detects pathologies in dental imaging to help dentists avoid missed diagnoses. | Biotech | Series B | $40.0M | 2025-01-28 | $66.5M | Spark Capital, Zetta Venture Partners, Pillar VC +2 | 51 to 100 | 2018 |
| ZOE | ZOE provides personalized nutrition programs aimed at improving people's health. | Health care | Series B | $15.0M | 2024-07-29 | $117.4M | Balderton Capital, Accomplice, L Catterton +1 | 251 to 500 | 2017 |
| Cardurion Pharmaceuticals | Cardurion Pharmaceuticals develops cardiovascular therapeutics for heart failure and related diseases. | Biotech | Series B | $260.0M | 2024-07-16 | $603.1M | New Enterprise Associates, Google Ventures, Fidelity +1 | 11 to 50 | 2017 |
| Form Health | Form Health provides evidence-based obesity care through virtual consultations with physicians and dietitians. | Health care | Series B | $38.0M | 2024-06-26 | $64.3M | SignalFire, M13, NextView Ventures +1 | 101 to 250 | 2019 |
| CodaMetrix | CodaMetrix offers an AI-powered medical coding platform for healthcare revenue cycle management. | Artificial intelligence | Series B | $40.0M | 2024-03-12 | $95.0M | SignalFire, Martin Ventures, Transformation Capital +1 | 101 to 250 | 2019 |
| Asimov | Asimov uses artificial intelligence to build tools for designing and manufacturing therapeutics. | Artificial intelligence | Series B | $175.0M | 2023-01-05 | $205.0M | Andreessen Horowitz, DCVC, Fidelity +2 | 101 to 250 | 2017 |
| Origin | Origin is a financial planning platform that manages employee compensation, benefits, and personal finances. | Artificial intelligence | Series B | $56.0M | 2021-08-30 | $72.0M | General Catalyst, Founders Fund, Felicis +2 | 101 to 250 | 2018 |
Table 1. Health care startups that raised Series B in Boston, Massachusetts: the 10 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 61.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Series B | $65.5M | 2026-09-03 | $223.5M | Insight Partners, RA Capital Management, NVentures | 11 to 50 | 2022 |
| 2 | Precede Biosciences | Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. | Biotech | Series B | $63.5M | 2026-01-12 | $140.5M | Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 | 11 to 50 | 2005 |
| 3 | Beacon Biosignals | Beacon Biosignals uses neurotechnology to measure brain activity for clinical trials and patient treatment. | Artificial intelligence | Series B | $11.0M | 2026-04-06 | $127.0M | General Catalyst, Half Court Ventures, Indicator Ventures +1 | 101 to 250 | 2019 |
Table 2. Health care startups that raised Series B in Boston, Massachusetts: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | General Catalyst | Venture capital firm | San Francisco, United States | 2 | 3% | 1 | Beacon Biosignals |
| 2 | Alumni Ventures | Angel group | Manchester, United States | 2 | 3% | ||
| 3 | Fidelity | Investment bank | Boston, United States | 2 | 3% | ||
| 4 | SignalFire | Venture capital firm | San Francisco, United States | 2 | 3% | ||
| 5 | Insight Partners | Private equity firm | New York, United States | 1 | 2% | 1 | Superluminal Medicines |
| 6 | RA Capital Management | Startup incubator | Boston, United States | 1 | 2% | 1 | Superluminal Medicines |
| 7 | NVentures | Corporate venture arm | Santa Clara, United States | 1 | 2% | 1 | Superluminal Medicines |
| 8 | Half Court Ventures | Venture capital firm | Boston, United States | 1 | 2% | 1 | Beacon Biosignals |
| 9 | Casdin Capital | Venture capital firm | New York, United States | 1 | 2% | 1 | Beacon Biosignals |
| 10 | Indicator Ventures | Micro VC fund | New York, United States | 1 | 2% | 1 | Beacon Biosignals |
| 11 | Qatar Investment Authority | Fund of funds | Doha, Qatar | 1 | 2% | 1 | Precede Biosciences |
| 12 | Lilly Asia Ventures | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Precede Biosciences |
| 13 | Bristol-Myers Squibb | Venture capital firm | New York, United States | 1 | 2% | 1 | Precede Biosciences |
| 14 | 5AM Ventures | Venture capital firm | Menlo Park, United States | 1 | 2% | 1 | Precede Biosciences |
| 15 | Illumina Ventures | Corporate venture arm | Foster City, United States | 1 | 2% | 1 | Precede Biosciences |
Table 3. Health care startups that raised Series B in Boston, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 37 | 61% | $3.5B |
| Software | 12 | 20% | $987.5M |
| Artificial intelligence | 10 | 16% | $916.6M |
| Hardware | 3 | 5% | $227.4M |
| Commerce | 2 | 3% | $59.4M |
| Fintech | 2 | 3% | $137.0M |
Table 4. Health care startups that raised Series B in Boston, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 61 | 100% | $40.0M |
Table 5. Health care startups that raised Series B in Boston, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 12% | $135.0M |
| September 2026 | 1 | 12% | $65.5M |
| June 2026 | 1 | 12% | $40.0M |
| April 2026 | 1 | 12% | $11.0M |
| January 2026 | 3 | 38% | $242.5M |
| November 2025 | 1 | 12% | $59.2M |
Table 6. Health care startups that raised Series B in Boston, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 11% | $494.0M |
| 2025 | 7 | 11% | $342.2M |
| 2024 | 8 | 13% | $685.5M |
| 2023 | 10 | 16% | $494.7M |
| 2022 | 6 | 10% | $187.6M |
| 2021 | 6 | 10% | $286.0M |
Table 7. Health care startups that raised Series B in Boston, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 8 | 13% |
| 2015 to 2019 | 29 | 48% |
| 2010 to 2014 | 12 | 20% |
| Before 2010 | 12 | 20% |
Table 8. Health care startups that raised Series B in Boston, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 12 | 20% |
| 11 to 50 | 23 | 39% |
| 51 to 100 | 10 | 17% |
| 101 to 250 | 10 | 17% |
| 251 to 500 | 2 | 3% |
| 501 to 1,000 | 1 | 2% |
| 1,001 to 5,000 | 1 | 2% |
Table 9. Health care startups that raised Series B in Boston, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series B and its headquarters is in Boston, Massachusetts. On 16 November 2026 that is 61 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 10 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 61 rows: 5 have no round amount, 0 no city and 5 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Boston, Massachusetts whose last round is Series B are on the list?
- 61, in the file dated 16 November 2026. 8 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 61 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.